Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
Abstract Background We investigated the prognostic predictive value of the combination of fluorodeoxyglucose (FDG)- and fluoromisonidazole (FMISO)-PET in patients with non-small cell lung carcinoma (NSCLC) treated with stereotactic body radiation therapy (SBRT). Patients and methods We prospectively...
Main Authors: | Shiro Watanabe, Tetsuya Inoue, Shozo Okamoto, Keiichi Magota, Ayumi Takayanagi, Jun Sakakibara-Konishi, Norio Katoh, Kenji Hirata, Osamu Manabe, Takuya Toyonaga, Yuji Kuge, Hiroki Shirato, Nagara Tamaki, Tohru Shiga |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-12-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-019-0578-6 |
Similar Items
-
Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors
by: Yukiko Nishikawa, et al.
Published: (2017-09-01) -
18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice
by: Wenjing Yu, et al.
Published: (2019-11-01) -
The Roles of Hypoxia Imaging Using <sup>18</sup>F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
by: Kenji Hirata, et al.
Published: (2019-07-01) -
[18F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer
by: Tomohiko Yamane, et al.
Published: (2019-05-01) -
Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.
by: Markus Kroenke, et al.
Published: (2019-01-01)